RSV Season Starts Slow in the South

The U.S. Centers for Disease Control and Prevention (CDC) recently reported that Respiratory Virus (RSV) activity remained low but is expected to increase.

In the U.S., the annual RSV season usually begins in Florida and then migrates to the southeast, later to the north and west regions. 

As of September 17, 2024, week #37, the Florida Department of Health reported increasing RSV positivity rates, decreasing hospital admissions, and no RSV outbreaks.

A recent study found that over the past few years, about 53% of children were infected with RSV during infancy, and 2.8% were hospitalized. 

Unlike previous RSV seasons, the U.S. is well prepared to reduce the impact of this respiratory disease.

As of September 20, 2024, three RSV vaccines have been approved, and the CDC recommends a passive immunization (Beyfortus™ (Nirsevimab-alip) for most infants. Based on each state, these U.S. FDA-approved products are offered at health clinics and pharmacies.